Amaros AI - The Ophthalmic Answer Engine™

From Fragmentation to Fluency

From Fragmentation to Fluency

From Fragmentation to Fluency

From Fragmentation to Fluency

Turning Data into Actionable Intelligence for Decision Making.

A portrait image focuses on a woman's face and her eyes looking into the distance.

Amaros, founded in 2018 in Silicon Valley, is a deep tech company delivering precision intelligence to power the future of ophthalmic care. By combining Al, clinical ophthalmology, and human-centric design, Amaros has developed a breakthrough, dynamic intelligence ecosystem that modernizes eye care research, delivery, and advancement.

Our proprietary EvidenceEngine™ platform integrates fragmented data-from EMRs and multimodal images to genetics, provider notes, and payor claims - into structured, real-time insights. Seamlessly embedded into existing workflows, Amaros empowers clinics, CROs, and therapeutic teams to streamline decisions, and improve patient outcomes. Amaros is transforming what's possible in ophthalmic innovation - one insight at a time. Our proprietary EvidenceEngine™ platform integrates fragmented data-from EMRs and multimodal images to genetics, provider notes, and payor claims - into structured, real-time insights. Seamlessly embedded into existing workflows, Amaros empowers clinics, CROs, and therapeutic teams to streamline decisions, and improve patient outcomes.

Amaros is transforming what's possible in ophthalmic innovation - one insight at a time.

Our team

Smiling emplyee in glasses sitting in an office chair, working on a laptop, exuding a relaxed and happy demeanor.

Diverse group of young professionals seated at a wooden table, engaged in collaborative work on their laptops.

Young adults at a coffee shop, focused on their laptops and engaged in discussion, in a casual and sunny outdoor setting.

Our team

Unique qualities that set us apart

Amaros has built the intelligence ecosystem for ophthalmology—transforming static data into dynamic, real-time insights that drive action. Powered by its proprietary platform, EvidenceEngine™, Amaros delivers tailored insights across the eye care continuum: helping physicians track disease progression, CROs optimize trials, and commercial teams uncover access gaps and new opportunities. But Amaros is more than a technology provider. We’re reimagining how intelligence is built, delivered, and used. By combining AI, domain expertise, and human-centered design to ensure every insight is not only advanced but accessible. In doing so, we enable the field to shift from fragmentation to fluency, from reaction to precision, from disconnected data to a unified future.

Our team

We come from diverse backgrounds and have decades of experience at the forefront of commercial and academic machine learning and ophthalmology.

Our technology

EvidenceEngine™ is Amaros’ proprietary AI platform purpose-built for ophthalmology. It unifies multimodal data—including EMRs, images, genetics, provider notes, and payor claims—into a dynamic intelligent ecosystem that delivers tailored, real-time intelligence.

Our customers

We empower clinics, CROs, and therapeutic teams to streamline decisions, and improve patient outcomes.

Our mission

Our mission is to transform ophthalmology by converting complex data into precision intelligence.

Category Creation

Amaros has created a new category: the first intelligence ecosystem for ophthalmology-uniting care, research, and commercialization in one dynamic, integrated foundation.

Evidence-Driven Intelligence

Through our proprietary plattorm, we transform fragmented ophthalmic data into unified, real-time intelligence to drive precise, dynamic, and personalized action.

Precision by Design

Amaros combines Al expertise with deep ophthalmic knowledge and product usability, creating solutions that are intuitive, effective, and easily implemented.

Interdisciplinary Integration

We stand at the intersection of data science, clinical practice, and therapeutic development—building the ecosystem that advances the field of ophthalmic care.